Skip to main content
SpringerLink
Log in

Anaphylaxis During General Anaesthesia

Prevention and Management

  • Disease Management
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Any drug administered in the peri-operative period has the potential to produce life-threatening immune-mediated anaphylaxis. The incidence of anaphylaxis has been estimated at between 1 in 10 000 and 1 in 20 000 anaesthesias in Australia and 1 in 13 000 anaesthesias in France. In the most recent French epidemiological survey, the compounds most frequently involved in anaphylaxis were muscle relaxants (60%), followed by latex (16%).

Activation of humoral and cellular pathways resulting from immunoglobulin E-mediated adverse reactions usually produces characteristic respiratory, cardiovascular and skin responses, but effects can be seen in virtually any system. These responses may occur as isolated clinical events. As a result, an anaphylacticreaction restricted to a single clinical symptom (e.g. bronchospasm, tachycardia) can easily be misdiagnosed. Intra- and postoperative investigations must be performed to confirm the nature of the adverse reaction, the role of the suspected drugs, and to define precise recommendations for future anaesthesias. The patient must be fully informed, and given a detailed written account of the anaphylactic episode, the results of the allergological assessment performed and the resulting recommendations. Furthermore, the patient should be strongly advise to wear a warning bracelet or carry a warning card.

Since no specific treatment has been proven to reliably prevent the onset of anaphylactic reactions, allergological assessment must be performed in all highrisk patients. The only possible strategy is to avoid the drug tested positively during the allergy work-up. Nevertheless, in cases where muscle relaxants are incriminated, patients allergic to one muscle relaxant can be administered another agent, the choice of which is based on skin test results. However, it should be borne in mind that rare cases of adverse reactions in spite of such screening procedures have been reported. On the contrary, there is no indication for allergological assessment in atopic patients who do not have additional anaesthetic agent risk factors or those allergic only to non-anaesthetic substances.

The treatment of anaphylaxis is aimed at interrupting contact with the responsible antigen, modulating the effects of released mediators, and inhibiting mediator production and release. Treatment must be initiated as quickly as possible, and relies on generally accepted principles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I
Table II
Table III
Fig. 3

Similar content being viewed by others

References

  1. Portier P, Richet C. De l’action anaphylactique de certains venins. CR Soc Biol 1902; 6: 170–2

    Google Scholar 

  2. Paton WDM. Histamine release by compounds of simple chemical structure. Pharmacol Rev 1957; 9: 269–328

    PubMed  CAS  Google Scholar 

  3. Watkins J, Ward AM, Thornton JA. Adverse reactions to intravenous induction agents [letter]. BMJ 1978; 2(6149): 1431

    Article  PubMed  CAS  Google Scholar 

  4. Lorenz W, Doenicke A, Feifel G, et al. Histamine release in man by propanidid (Epontol), gelatin (Haemaccel), histalog, pentagastrin and insulin. Naunyn Schmiedebergs Arch Pharmacol 1970; 266(4): 396–7

    Article  PubMed  CAS  Google Scholar 

  5. Lorenz W, Doenicke A, Schoning B, et al. Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject. Klin Wochenschr 1982; 60(17): 896–913

    Article  PubMed  CAS  Google Scholar 

  6. Jerums G, Whittingham S, Wilson P. Anaphylaxis to suxamethonium: a case report. Br J Anaesth 1967; 39(1): 73–7

    Article  PubMed  CAS  Google Scholar 

  7. Fisher MM. Intradermal testing after severe histamine reactions to intravenous drugs used in anaesthesia. Anaesth Intensive Care 1976; 4(2): 97–104

    PubMed  CAS  Google Scholar 

  8. Sigiel M, Laxenaire MC, Moneret-Vautrin DA, et al. Trois cas de choc anaphylactique à la Célocurine. Anesth Analg (Paris) 1975; 32: 447–62

    CAS  Google Scholar 

  9. Vervloet D, Arnaud A, Vellieux P, et al. Anaphylactic type of accidents due to myorelaxing agents during general anesthesia: clinical and biological study [in French]. Nouv Presse Med 1977; 6(9): 725–8

    PubMed  CAS  Google Scholar 

  10. Galletly DC, Treuren BC. Anaphylactoid reactions during anaesthesia: seven years’ experience of intradermal testing. Anaesthesia 1985; 40(4): 329–33

    Article  PubMed  CAS  Google Scholar 

  11. Leynadier F, Sansarricq M, Didier JM, et al. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987; 59(6): 683–9

    Article  PubMed  CAS  Google Scholar 

  12. Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs: practical aspects of performance and interpretation. Anaesth Intensive Care 1984; 12(2): 115–20

    PubMed  CAS  Google Scholar 

  13. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983; 306(5940): 262–4

    Article  PubMed  CAS  Google Scholar 

  14. Assem ESK. Anaphylactoid reactions to neuromuscular blockers: major role of IgE antibodies and possible contribution of IgE-independent mechanisms. In: Assem ESK, editor. Allergic reactions to anaesthetics: clinical and basic aspects. Basel: Karger, 1992: 24–53

    Google Scholar 

  15. Baldo BA, Fisher MM, Harle DG. Allergy to thiopentone. Clin Rev Allergy 1991; 9(3–4): 295–308

    PubMed  CAS  Google Scholar 

  16. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, et al. Life-threatening anaphylactoid reactions to propofol (diprivan) [see comments]. Anesthesiology 1992; 77(2): 275–80

    Article  PubMed  CAS  Google Scholar 

  17. Laxenaire MC. Encore et toujours l’allergie. Ann Fr Anesth Reanim 1999; 18: 831–3

    Article  PubMed  CAS  Google Scholar 

  18. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12(2): 97–104

    Article  PubMed  CAS  Google Scholar 

  19. Laxenaire MC. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999; 18: 796–809

    Article  CAS  Google Scholar 

  20. Sage D, Guarino R, Sage DD. Intradermal drug testing following anaphylactoid reactions during anaesthesia. Anaesth Intensive Care 1981; 9(4): 381–6

    PubMed  CAS  Google Scholar 

  21. Pepys J, Pepys EO, Baldo BA, et al. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents: skin prick tests in aetiological diagnosis. Anaesthesia 1994; 49(6): 470–5

    Article  PubMed  CAS  Google Scholar 

  22. Moscicki RA, Sockin SM, Corsello BF, et al. Anaphylaxis during induction of general anesthesia: subsequent evaluation and management [see comments]. J Allergy Clin Immunol 1990; 86 (3 Pt 1): 325–32

    Article  PubMed  CAS  Google Scholar 

  23. Knowles SR, Weber E, Shear NH. Allergic reactions during general anesthesia (GA) [abstract]. J Allergy Clin Immunol 1996; 97: 344

    Article  Google Scholar 

  24. Keith PK, Dolovich J. Anaphylactic and anaphylactoid reactions in the perioperative period. Immunol Allergy Clin North Am 1992; 12(3): 671–90

    Google Scholar 

  25. Watkins J. Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand Suppl 1994; 102: 6–10

    Article  PubMed  CAS  Google Scholar 

  26. Laxenaire MC, Moneret-Vautrin DA. Allergy and anaesthesia. Curr Opin Anaesthesiol 1992; 5: 436–41

    Article  Google Scholar 

  27. Moneret-Vautrin DA, Laxenaire MC. The risk of allergy related to general anaesthesia. Clin Exp Allergy 1993; 23(8): 629–33

    Article  PubMed  CAS  Google Scholar 

  28. Gold M, Swartz JS, Braude BM, et al. Intraoperative anaphylaxis: an association with latex sensitivity. J Allergy Clin Immunol 1991; 87(3): 662–6

    Article  PubMed  CAS  Google Scholar 

  29. Warpinski JR, Folgert J, Cohen M, et al. Allergic reaction to latex: a risk factor for unsuspected anaphylaxis. Allergy Proc 1991; 12(2): 95–102

    Article  PubMed  CAS  Google Scholar 

  30. Moneret-Vautrin DA, Laxenaire MC, Gueant JL. Anaphylactic reactions to muscle relaxants. In: Pichler WJ, Stadler BM, Dahinden C, et al., editors. Progress in allergy and clinical immunology. Proceedings of the 13th International Congress of Allergology and Clinical Immunology: 1988 Oct 16–22; Montreux. Bern: Hogrefe & Huber, 1989: 450–4

    Google Scholar 

  31. Baird MB, Futter M. Anaphylaxis to mivacurium. Anaesth Intensive Care 1996; 24(4): 486–8

    PubMed  CAS  Google Scholar 

  32. Yee R, Fernandez JA. Anaphylactic reaction to rocuronium bromide. Anaesth Intensive Care 1996; 24(5): 601–4

    PubMed  CAS  Google Scholar 

  33. Barthelet Y, Ryckwaert Y, Plasse C, et al. Severe anaphylactic reactions to rocuronium bromide. Ann Fr Anesth Reanim 1999; 18: 896–900

    Article  PubMed  CAS  Google Scholar 

  34. Toh KW, Deacock SJ, Fawcett WJ. Severe anaphylactic reaction to cisatracurium. Anesth Analg 1999; 88(2): 462–4

    PubMed  CAS  Google Scholar 

  35. Laxenaire MC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia: a French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993; 12(2): 91–6

    Article  PubMed  CAS  Google Scholar 

  36. Laxenaire MC. Substances responsible for peranesthetic anaphylactic shock: a third French multicenter study (1992–94) [in French]. Ann Fr Anesth Reanim 1996; 15(8): 1211–8

    Article  PubMed  CAS  Google Scholar 

  37. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80(1): 26–9

    Article  PubMed  CAS  Google Scholar 

  38. Fisher M, Baldo BA. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 1994; 11(4): 263–84

    PubMed  CAS  Google Scholar 

  39. Porri F, Lemiere C, Birnbaum J, et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999; 29(1): 72–5

    Article  PubMed  CAS  Google Scholar 

  40. Moneret-Vautrin DA, Renaudin JM, Kanny G, et al. Prospective study of the latent sensitization to muscle relaxants. In: Dehling AK, Huerat-Lopez JG, editors. Progress in allergy and clinical immunology. Cancun: Hogrefe and Huber, 1997: 361–76

    Google Scholar 

  41. Albrech C, Widmer S, Beaudoin E, et al. Prospective study of sensitization to muscle relaxants [abstract]. J Allergy Clin Immunol 1995; 95: 289

    Google Scholar 

  42. Laroche D, Lefrancois C, Gerard JL, et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 1992; 69(6): 611–4

    Article  PubMed  CAS  Google Scholar 

  43. Laroche D, Dubois F, Lefrancois C, et al. Early biological markers of anaphylactoid reactions occurring during anesthesia [in French]. Ann Fr Anesth Reanim 1992; 11(6): 613–8

    Article  PubMed  CAS  Google Scholar 

  44. Laroche D, Vergnaud MC, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs: comparison of plasma histamine and tryptase. Anesthesiology 1991; 75(6): 945–9

    Article  PubMed  CAS  Google Scholar 

  45. Aimone-Gastin I, Gueant JL, Laxenaire MC, et al. Pathogenesis of allergic reactions to anaesthetic drugs. Int J Immunopathol Pharmacol 1997; 10(2): 193–6

    CAS  Google Scholar 

  46. de Weck AL. Immunochemical particularities of anaphylactic reactions to compounds used in anesthesia. Ann Fr Anesth Reanim 1993; 12(2): 126–30

    Article  PubMed  Google Scholar 

  47. Falk K, Rotzschke O, Stevanovic S, et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351(6324): 290–6

    Article  PubMed  CAS  Google Scholar 

  48. Romagnoli P, Labhardt AM, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991; 10(6): 1303–6

    PubMed  CAS  Google Scholar 

  49. van den Broeke LT, Heffler LC, Tengvall-Linder M, et al. Direct Ni2+ antigen formation on cultured human dendritic cells. Immunology 1999; 96: 578–85

    Article  Google Scholar 

  50. Fisher MM. Anaphylaxis to muscle relaxants: cross sensitivity between relaxants. Anaesth Intensive Care 1980; 8(2): 211–3

    PubMed  CAS  Google Scholar 

  51. Vervloet D, Arnaud A, Vellieux P, et al. Anaphylactic reactions to muscle relaxants under general anesthesia. J Allergy Clin Immunol 1979; 63(5): 348–53

    Article  PubMed  CAS  Google Scholar 

  52. Baldo BA, Harle DG. Drug allergenic determinants. In: Baldo BA, editor. Molecular approaches to the study of allergens. Monographs in allergy. Basel: Karger, 1990: 11–51

    Google Scholar 

  53. Birnbaum J, Vervloet D. Allergy to muscle relaxants. Clin Rev Allergy 1991; 9(3–4): 281–93

    PubMed  CAS  Google Scholar 

  54. Leynadier F, Dry J. Anaphylaxis to muscle-relaxant drugs: study of cross-reactivity by skin tests. Int Arch Allergy Appl Immunol 1991; 94(1–4): 349–53

    Article  PubMed  CAS  Google Scholar 

  55. Fisher MM, Harle DG, Baldo BA. Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 1991; 9(3–4): 309–18

    PubMed  CAS  Google Scholar 

  56. Fisher MM, Baldo BA. The diagnosis of fatal anaphylactic reactions during anaesthesia: employment of immunoassays for mast cell tryptase and drug-reactive IgE antibodies. Anaesth Intensive Care 1993; 21(3): 353–7

    PubMed  CAS  Google Scholar 

  57. Levy JH. Allergic reactions during anesthesia [clinical conference]. J Clin Anesth 1988; 1(1): 39–46

    Article  PubMed  CAS  Google Scholar 

  58. Stellato C, de Paulis A, Cirillo R, et al. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 1991; 74(6): 1078–86

    Article  PubMed  CAS  Google Scholar 

  59. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14(1): 17–21

    PubMed  CAS  Google Scholar 

  60. Fisher M. Treatment of acute anaphylaxis [(see comments) published erratum appears in BMJ 1995 Oct 7; 311(7010): 937]. BMJ 1995; 311(7007): 731–3

    Article  PubMed  CAS  Google Scholar 

  61. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; I(8009): 466–9

    Article  Google Scholar 

  62. Douglas DM, Sukenick E, Andrade WP, et al. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994; 93(6): 977–85

    Article  PubMed  CAS  Google Scholar 

  63. Leynadier F, Pecquet C, Dry J. Anaphylaxis to latex during surgery. Anaesthesia 1989; 44(7): 547–50

    Article  PubMed  CAS  Google Scholar 

  64. Moneret-Vautrin DA, Laxenaire MC. Anaphylactic and anaphylactoid reactions: clinical presentation. Clin Rev Allergy 1991; 9(3–4): 249–58

    PubMed  CAS  Google Scholar 

  65. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms: aFrench multicenter prospective study [(see comments) in French]. Ann Fr Anesth Reanim 1994; 13(3): 301–10

    Article  PubMed  CAS  Google Scholar 

  66. Steiner DJ, Schwager RG. Epidemiology, diagnosis, precautions, and policies of intraoperative anaphylaxis to latex [see comments]. J Am Coll Surg 1995; 180(6): 754–61

    PubMed  CAS  Google Scholar 

  67. Cardot E, Tillie-Leblond I, Jeannin P, et al. Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol 1995; 95 (1 Pt 1): 1–7

    Article  PubMed  CAS  Google Scholar 

  68. Laxenaire MC, Mouton C, Frederic A, et al. Anaphylactic shock after tourniquet removal in orthopedic surgery [abstract]. Ann Fr Anesth Reanim 1996; 15(2): 179–84

    Article  PubMed  CAS  Google Scholar 

  69. Watkins J. Immediate hypersensitivity-type reactions in anaesthesia: allergy or otherwise, a problem or an overstatement. Theor Surg 1991; 6: 229–35

    Google Scholar 

  70. Lorenz W, Neugebauer E, Uvnas B, et al. Munich consensus development conference on histamine determination. In: Uvnas B, editor. Handbook of experimental pharmacology, histamine and histamine antagonists. Berlin: Springer-Verlag, 1991: 81–92

    Google Scholar 

  71. Matsson P, Enander I, Andersson AS, et al. Evaluation of mast cell activation (tryptase) in two patients suffering from druginduced hypotensoid reactions. Agents Actions 1991; 33(1–2): 218–20

    Article  PubMed  CAS  Google Scholar 

  72. Veien M, Szlam F, Holden JT, et al. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000; 92: 1074–81

    Article  PubMed  CAS  Google Scholar 

  73. Moneret-Vautrin DA, Laxenaire MC. Anaphylaxis to muscle relaxants: predictive tests [letter]. Anaesthesia 1990; 45(3): 246–7

    Article  PubMed  CAS  Google Scholar 

  74. Fisher MM, Baldo BA. Persistence of allergy to anaesthetic drugs. Anaesth Intensive Care 1992; 20(2): 143–6

    PubMed  CAS  Google Scholar 

  75. Laxenaire MC, Moneret-Vautrin DA. Le risque allergique en anesthésie-réanimation. In: Lemaire F, Desmonts JM, editors. Collection d’Anesthésiologie et de Réanimation. Paris: Masson, 1990:1–154

    Google Scholar 

  76. Fisher MM, Bowey CJ. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79(1): 59–63

    Article  PubMed  CAS  Google Scholar 

  77. Moneret-Vautrin DA, Laxenaire MC. Skin tests in diagnosis of allergy to muscle relaxants and other anaesthetic drugs. In: Assem ES, editor. Allergic reactions to anaesthetics: clinical and basic aspects. Basel: Karger, 1992: 145–55

    Google Scholar 

  78. Galletly DC. Comparative cutaneous histamine release by neuromuscular blocking agents. Anaesth Intensive Care 1986; 14(4): 365–9

    PubMed  CAS  Google Scholar 

  79. Laxenaire MC, Gastin I, Moneret-Vautrin DA, et al. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol Suppl 1995; 11: 55–64

    PubMed  CAS  Google Scholar 

  80. Moneret-Vautrin DA, Gueant JL, Kamel L, et al. Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases. J Allergy Clin Immunol 1988; 82 (5 Pt 1): 745–52

    Article  PubMed  CAS  Google Scholar 

  81. McKinnon RP, Wildsmith JA. Histaminoid reactions in anaesthesia. Br J Anaesth 1995; 74(2): 217–28

    Article  PubMed  CAS  Google Scholar 

  82. Assem ES. Anaphylactic anaesthetic reactions: the value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone. Anaesthesia 1990; 45(12): 1032–8

    Article  PubMed  CAS  Google Scholar 

  83. Gueant JL, Mata E, Monin B, et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991; 46(6): 452–8

    Article  PubMed  CAS  Google Scholar 

  84. Gueant JL, Masson C, Laxenaire MC. Biological tests for diagnosing the IgE-mediate allergy to anaesthetic drugs. In: Assem K, editor. Monographs in allergy. Basel: Karger, 1992: 94–107

    Google Scholar 

  85. Guilloux L, Ricard-Blum S, Ville G, et al. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992; 90(2): 153–9

    Article  PubMed  CAS  Google Scholar 

  86. Guilloux L, Richard-Blum S, Ville G, et al. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs. Ann Fr Anesth Reanim 1993; 12(2): 182–6

    Article  PubMed  CAS  Google Scholar 

  87. Gueant JL, Mata E, Monin B. Evaluation clinique et biologique d’un test radio-immunologique de détection des IgE sériques spécifiques des curarisants. In: Galteau M, Siest G, Henny J, editors. Biologic prospective. Paris: Libbey Eurotext, 1989: 737–40

    Google Scholar 

  88. Moneret-Vautrin DA, Widmer S, Gueant JL, et al. Simultaneous anaphylaxis to thiopentone and a neuromuscular blocker: a study of two cases. Br J Anaesth 1990; 64(6): 743–5

    Article  PubMed  CAS  Google Scholar 

  89. Gueant JL, Mata E, Masson C, et al. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs. Mol Immunol 1995; 32(4): 259–66

    Article  PubMed  CAS  Google Scholar 

  90. Moneret-Vautrin DA, Finet JF, Maria Y. L’allergie au latex. Revue Française d’Allergologie 1988; 183: 235–6

    Google Scholar 

  91. Mata E, Gueant JL, Moneret-Vautrin DA, et al. Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs. Allergy 1992; 47(5): 471–6

    Article  PubMed  CAS  Google Scholar 

  92. Sainte-Laudy J, Vallon C, Guerin JC. Analysis of membrane expression of the CD63 human basophil activation marker: applications to allergologic diagnosis [in French]. Allerg Immunol (Paris) 1994; 26(6): 211–4

    CAS  Google Scholar 

  93. Abuaf N, Rajoely B, Ghazouani E, et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999; 104 (2 Pt 1): 411–8

    Article  PubMed  CAS  Google Scholar 

  94. Laroche D, Bricard H, Laxenaire MC. Allergo-anesthesia consultation: not enough patients are tested after an anaphylactoid anesthetic incident [(letter; comment) in French]. Ann Fr Anesth Reanim 1998; 17(1): 89–90

    Article  PubMed  CAS  Google Scholar 

  95. Fisher MM. The prevention of second anaphylactoid reactions to anaesthetic drugs. Anaesth Intensive Care 1981; 9(3): 242–6

    PubMed  CAS  Google Scholar 

  96. Charpin D, Benzarti M, Hemon Y, et al. Atopy and anaphylactic reactions to suxamethonium. J Allergy Clin Immunol 1988; 82 (3 Pt 1): 356–60

    Article  PubMed  CAS  Google Scholar 

  97. Guldager H, Sondergaard I. Histamine release from basophil leukocytes in asthma patients after in vitro provocation with various neuromuscular blocking drugs and intravenous anaesthetic agents. Acta Anaesthesiol Scand 1987; 31(8): 728–9

    Article  PubMed  CAS  Google Scholar 

  98. Akagi K, Townley RG. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma. J Allergy Clin Immunol 1989; 83(4): 742–9

    Article  PubMed  CAS  Google Scholar 

  99. Laxenaire M, Mata E, Guéant J, et al. Basophil histamine release in atopic patients after in vitro provocation with thiopental, diprivan and chlormethiazole. Acta Anaesthesiol Scand 1991; 35: 706–10

    Article  PubMed  CAS  Google Scholar 

  100. Naguib M, Samarkandi AH, Bakhamees HS, et al. Histaminerelease haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine [see comments]. Br J Anaesth 1995; 75(5): 588–92

    Article  PubMed  CAS  Google Scholar 

  101. Fuchs T, Spitzauer S, Vente C, et al. Natural latex, grass pollen, and weed pollen share IgE epitopes. J Allergy Clin Immunol 1997; 100(3): 356–64

    Article  PubMed  CAS  Google Scholar 

  102. Moneret-Vautrin DA, Beaudouin E, Widmer S, et al. Prospective study of risk factors in natural rubber latex hypersensitivity. J Allergy Clin Immunol 1993; 92(5): 668–77

    Article  PubMed  CAS  Google Scholar 

  103. Kelly KJ, Pearson ML, Kurup VP, et al. Acluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 1994; 94(1): 53–61

    Article  PubMed  CAS  Google Scholar 

  104. Konrad C, Fieber T, Gerber H, et al. The prevalence of latex sensitivity among anesthesiology staff. Anesth Analg 1997; 84(3): 629–33

    PubMed  CAS  Google Scholar 

  105. Lebenbom-Mansour MH, Oesterle JR, Ownby DR, et al. The incidence of latex sensitivity in ambulatory surgical patients: a correlation of historical factors with positive serum immunoglobin E levels [see comments]. Anesth Analg 1997; 85(1): 44–9

    PubMed  CAS  Google Scholar 

  106. Cuesta-Herranz J, de las Heras M, Fernandez M, et al. Allergic reaction caused by local anesthetic agents belonging to the amide group [see comments]. J Allergy Clin Immunol 1997; 99(3): 427–8

    Article  PubMed  CAS  Google Scholar 

  107. Ismail K, Simpson PJ. Anaphylactic shock following intravenous administration of lignocaine. Acta Anaesthesiol Scand 1997; 41(8): 1071–2

    Article  PubMed  CAS  Google Scholar 

  108. Fisher MM, Bowey CJ. Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25(6): 611–4

    PubMed  CAS  Google Scholar 

  109. Clendenen SR, Harper JV, Wharen Jr RE, et al. Anaphylactic reaction after cisatracurium. Anesthesiology 1997; 87(3): 690–2

    Article  PubMed  CAS  Google Scholar 

  110. Leynadier F, Calinaux C, Dry J. Predictive value of intradermal tests using muscle-relaxing drugs [in French]. Ann Fr Anesth Reanim 1989; 8(2): 98–101

    Article  PubMed  CAS  Google Scholar 

  111. Thacker MA, Davis FM. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 1999; 27(2): 190–3

    PubMed  CAS  Google Scholar 

  112. Fisher MM. Anaphylactoid reactions during anaesthesia. In: Prys-Roberts C, editor. International practice of anaesthesia. Oxford: Butterworth-Heinemann, 1996: 1–13

    Google Scholar 

  113. Fisher MM, Merefield D, Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 1999; 82(5): 770–3

    Article  PubMed  CAS  Google Scholar 

  114. Shenot P, Rivas DA, Kaiman DD, et al. Latex allergy manifested in urological surgery and care of adult spinal cord injured patients. Arch Phys Med Rehabil 1994; 75(11): 1263–5

    Article  PubMed  CAS  Google Scholar 

  115. Ellsworth PI, Merguerian PA, Klein RB, et al. Evaluation and risk factors of latex allergy in spina bifida patients: is it preventable? J Urol 1993; 150 (2 Pt 2): 691–3

    PubMed  CAS  Google Scholar 

  116. Slater JE. Rubber anaphylaxis [see comments]. N Engl J Med 1989; 320(17): 1126–30

    Article  PubMed  CAS  Google Scholar 

  117. Bouaziz H, Laxenaire MC. Anaesthesia for the allergic patient. Current Opinion in Anaesthesiology 1998; 11: 339–44

    Article  PubMed  CAS  Google Scholar 

  118. Tarlo SM, Sussman GL, Holness DL. Latex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol 1997; 99(3): 396–401

    Article  PubMed  CAS  Google Scholar 

  119. Mazon A, Nieto A, Estornell F, et al. Factors that influence the presence of symptoms caused by latex allergy in children with spina bifida. J Allergy Clin Immunol 1997; 99(5): 600–4

    Article  PubMed  CAS  Google Scholar 

  120. Porri F, Pradal M, Lemiere C, et al. Association between latex sensitization and repeated latex exposure in children. Anesthesiology 1997; 86(3): 599–602

    Article  PubMed  CAS  Google Scholar 

  121. Ylitalo L, Turjanmaa K, Palosuo T, et al. Natural rubber latex allergy in children who had not undergone surgery and children who had undergone multiple operations. J Allergy Clin Immunol 1997; 100(5): 606–12

    Article  PubMed  CAS  Google Scholar 

  122. Brehler R, Theissen U, Mohr C, et al. ‘Latex-fruit syndrome’: frequency of cross-reacting IgE antibodies. Allergy 1997; 52(4): 404–10

    Article  PubMed  CAS  Google Scholar 

  123. Youngman PR, Taylor KM, Wilson JD. Anaphylactoid reactions to neuromuscular blocking agents: a commonly undiagnosed condition? Lancet 1983; II(8350): 597–9

    Article  Google Scholar 

  124. Assem ES, Ling YB. Fatal anaphylactic reaction to suxamethonium: new screening test suggests possible prevention [see comments]. Anaesthesia 1988; 43(11): 958–61

    Article  PubMed  CAS  Google Scholar 

  125. Brahams D. Fatal reaction to suxamethonium: case for screening by radioallergosorbent test? [see comments]. Lancet 1989; 1(8651): 1400–1

    Article  PubMed  CAS  Google Scholar 

  126. Porri F, Lemiere C, Birnbaum J, et al. Prevalence of latex sensitization in subjects attending health screening: implications for a perioperative screening. Clin Exp Allergy 1997; 27(4): 413–7

    Article  PubMed  CAS  Google Scholar 

  127. Ostergaard D, Engbaek J, Viby-Mogensen J. Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp 1989; 4(5): 351–68

    Article  PubMed  CAS  Google Scholar 

  128. Fisher MM, Brady PW. Adverse reactions to plasma volume expanders. Drug Saf 1990; 5(2): 86–93

    Article  PubMed  CAS  Google Scholar 

  129. Lorenz W, Röhrer HD, Doenicke A. Histamine release in anaesthetic and surgery: a new method to evaluate its clinical significance with several types of causal relationship. Clin Anaesthesiol 1984; 2: 403–26

    Google Scholar 

  130. Fisher M. Direct histamine release in anaesthesia and surgery: unanswered questions. Theor Surg 1988; 3: 145–7

    Google Scholar 

  131. Hobsley M, Moss J, Levi R, et al. Discussion forum about a protocol of a controlled clinical trial: induction of anaesthesia and perioperative risk. Theor Surg 1988; 3: 55–77

    Google Scholar 

  132. Lorenz W, Ennis M, Doenicke A, et al. Perioperative uses of histamine antagonists [published erratum appears in J Clin Anesth 1991 Mar-Apr; 3 (2): 170]. J Clin Anesth 1990; 2(5): 345–60

    Article  PubMed  CAS  Google Scholar 

  133. Schwartz A, Sutton SL, Askenase PW, et al. Histamine inhibition of concanavalin A-induced suppressor T-cell activation. Cell Immunol 1981; 60(2): 426–39

    Article  PubMed  CAS  Google Scholar 

  134. Lichtenstein LM, Gillespie E. Inhibition of histamine release by histamine controlled by H2 receptor. Nature 1973; 244(5414): 287–8

    Article  PubMed  CAS  Google Scholar 

  135. Hutchcroft BJ, Moore EG, Orange RP. The effects of H1- and H2-receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis. J Allergy Clin Immunol 1979; 63(6): 376–82

    Article  PubMed  CAS  Google Scholar 

  136. Meyrick Thomas RH, Browne PD, Kirby JDT. The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reaction in human skin. J Allergy Clin Immunol 1985; 76(6): 864–9

    Article  PubMed  CAS  Google Scholar 

  137. Koga Y, Iwatsuki N, Hashimoto Y. Direct effects of H2-receptor antagonists on airway smooth muscle and on responses mediated by H1- and H2-receptors. Anesthesiology 1987; 66: 181–5

    Article  PubMed  CAS  Google Scholar 

  138. Ring J, Behrendt H. H1- and H2-antagonists in allergic and pseudoallergic diseases. Clin Exp Allergy 1990; 20 Suppl. 2: 43–9

    Article  Google Scholar 

  139. Lorenz W, Doenicke A. H1 and H2 blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: pt II. N Engl Reg Allergy Proc 1985; 6(2): 174–94

    Article  PubMed  CAS  Google Scholar 

  140. Dorsch W, Reimann HJ, Neuhauser J. Histamine l-histamine2 antagonism: effect of combined clemastine and cimetidine pretreatment on allergen and histamine-induced reactions of the guinea pig lung in vivo and in vitro. Agents Actions 1982; 12(1–2): 113–8

    Article  PubMed  CAS  Google Scholar 

  141. Lieberman P. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reations. J Allergy Clin Immunol 1990; 86: 684–6

    Article  PubMed  CAS  Google Scholar 

  142. Lorenz W, Doenicke A, Schoning B, et al. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs. Agents Actions 1980; 10 (1 Pt2): 114–24

    Article  PubMed  CAS  Google Scholar 

  143. Philbin DM, Moss J, Akins CW, et al. The use of H1 and H2 histamine antagonists with morphine anesthesia: a doubleblind study. Anesthesiology 1981; 55(3): 292–6

    Article  PubMed  CAS  Google Scholar 

  144. Hosking MP, Lennon RL, Gronert GA. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of highdose atracurium for rapid sequence endotracheal intubation. Anesth Analg 1988; 67(11): 1089–92

    PubMed  CAS  Google Scholar 

  145. Doenicke A, Moss J, Lorenz W, et al. Effect of oral antihistamine premedication on mivacurium-induced histamine release and side effects. Br J Anaesth 1996; 77(3): 421–3

    Article  PubMed  CAS  Google Scholar 

  146. Renz CL, Laroche D, Thurn JD, et al. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998; 89(3): 620–5

    Article  PubMed  CAS  Google Scholar 

  147. Renz CL, Thurn JD, Finn HA, et al. Antihistamine prophylaxis permits rapid vancomycin infusion [see comments]. Crit Care Med 1999; 27(9): 1732–7

    Article  PubMed  CAS  Google Scholar 

  148. Moss J, Roizen MF, Nordby EJ, et al. Decreased incidence and mortality of anaphylaxis to chymopapain. Anesth Analg 1985; 64(12): 1197–201

    Article  PubMed  CAS  Google Scholar 

  149. Lorenz W, Duda D, Dick W, et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg [see comments]. Lancet 1994; 343(8903): 933–40

    CAS  Google Scholar 

  150. Dahl JB. Antihistamine prophylaxis and general anaesthesia [see comments]. Lancet 1994; 343(8903): 929–30

    Article  PubMed  CAS  Google Scholar 

  151. Setlock MA, Cotter TP, Rosner D. Latex allergy: failure of prophylaxis to prevent severe reaction. Anesth Analg 1993; 76(3): 650–2

    Article  PubMed  CAS  Google Scholar 

  152. Kwittken PL, Sweinberg SK, Campbell DE, et al. Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics 1995; 95: 693–9

    PubMed  CAS  Google Scholar 

  153. Powell JA, Maycock EJ. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesth Intensive Care 1993; 21(5): 702–3

    PubMed  CAS  Google Scholar 

  154. Patterson LJ, Milne B. Latex anaphylaxis causing heart block: role of ranitidine. Can J Ansth 1999; 46(8): 776–8

    Article  CAS  Google Scholar 

  155. McKinnon RP. Allergic reactions during anaesthesia. Curr Opin Anaesthesiol 1996; 9: 267–70

    Article  Google Scholar 

  156. Birnbaum J, Porri F, Pradal M, et al. Allergy during anaesthesia. Clin Exp Allergy 1994; 24(10): 915–21

    Article  PubMed  CAS  Google Scholar 

  157. Ljungstrom KG, Willman B, Hedin H. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1. Ann Fr Anesth Reanim 1993; 12(2): 219–22

    CAS  Google Scholar 

  158. Ljungstrom KG, Renck H, Hedin H, et al. Hapten inhibition and dextran anaphylaxis. Anaesthesia 1988; 43(9): 729–32

    Article  PubMed  CAS  Google Scholar 

  159. Hedin H, Ljungstrom KG. Prevention of dextran anaphylaxis: ten years experience with hapten dextran. Int Arch Allergy Immunol 1997; 113 (1–3): 358–9

    Article  PubMed  CAS  Google Scholar 

  160. Berg EM, Fasting S, Sellevold OF. Serious complications with dextran-70 despite hapten prophylaxis: is it best avoided prior to delivery? Anaesthesia 1991; 46(12): 1033–5

    Article  PubMed  CAS  Google Scholar 

  161. Vervloet D, Arnaud A, Senft M, et al. Anaphylactic reactions to suxamethonium: prevention of mediator release by choline. J Allergy Clin Immunol 1985 (76): 222–5

  162. Thomas H, Eledjam JJ, Macheboeuf M, et al. Rapid pre-operative immunotherapy in a patient allergic to muscle relaxants. Eur J Anaesthesiol 1988; 5(6): 385–9

    PubMed  CAS  Google Scholar 

  163. Moneret-Vautrin DA, Kanny G, Gueant JL, et al. Prevention by monovalent haptens of IgE-dependent leucocyte histamine release to muscle relaxants. Int Arch Allergy Immunol 1995; 107(1–3): 172–5

    Article  PubMed  CAS  Google Scholar 

  164. Moneret-Vautrin DA, Laxenaire MC. Routine testing for latex allergy in patients with spina bifida [reply]. Anesthesiology 1991; 74: 391–2

    Article  Google Scholar 

  165. Ebo DG, Stevens WJ, Bridts CH, et al. Latex-specific IgE, skin testing, and lymphocyte transformation to latex in latex allergy. J Allergy Clin Immunol 1997; 100(5): 618–23

    Article  PubMed  CAS  Google Scholar 

  166. Porri F, Pradal M, Rud C, et al. Is systematic preoperative screening for muscle relaxant and latex allergy advisable? Allergy 1995; 50(4): 374–7

    Article  Google Scholar 

  167. Theissen JL, Zahn P, Theissen U, et al. Allergic and pseudo-allergic reactions in anesthesia. I: pathogenesis, risk factors, substances [in French]. Anasthesiol Intensivmed Notfallmed Schmerzther 1995; 30(1): 3–12

    CAS  Google Scholar 

  168. SFAR. Indications de la curarisation en Anesthésie. Conférence de Consensus. Texte court. Société Française d’Anesthésie et de Réanimation; 1999 Jul 12; Saint-Mandé. Available from: URL: http://www.sfar.org/curarisationccons.html [Accessed 2000 May 16]

  169. Birmingham PK, Dsida RM, Grayhack JJ, et al. Do latex precautions in children with myelodysplasia reduce intraoperative allergic reactions?J Pediatr Orthop 1996; 16(6): 799–802

    Article  PubMed  CAS  Google Scholar 

  170. Holzman RS. Clinical management of latex-allergic children. Anesth Analg 1997; 85(3): 529–33

    PubMed  CAS  Google Scholar 

  171. Heilman DK, Jones RT, Swanson MC, et al. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room. J Allergy Clin Immunol 1996; 98(2): 325–30

    Article  PubMed  CAS  Google Scholar 

  172. Laxenaire MC. Choc anaphylactique peranesthésique: conduite à tenir. Ann Fr Anesth Reamin 1997; 16(7): 2–4

    Google Scholar 

  173. Laxenaire MC, Moneret-Vautrin DA. Immunology: allergy and anaesthesia. Oether 1994; I: 14–18

    Google Scholar 

  174. The use of epinephrine in the treatment of anaphylaxis: American Academy of Allergy and Immunology board of Directors. Clin Immunol 1994; 94: 666-8

  175. Ewan PW. Anaphylaxis [published erratum appears in BMJ 1998 May 23; 316 (7144): 1507]. BMJ 1998; 316(7142): 1442–5

    Article  PubMed  CAS  Google Scholar 

  176. Heilborn H, Hjemdahl P, Daleskog M, et al. Comparison of subcutaneous injection and high-dose inhalation of epinephrine: implications for self-treatment to prevent anaphylaxis. J Allergy Clin Immunol 1986; 78(6): 1174–9

    Article  PubMed  CAS  Google Scholar 

  177. Simons FE, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101 (1 Pt 1): 33–7

    Article  PubMed  CAS  Google Scholar 

  178. Plomley RF, Czarny D. Inhaled adrenaline in the treatment of anaphylaxis [letter]. Med J Aust 1988; 149(10): 564

    PubMed  CAS  Google Scholar 

  179. Powers RD, Donowitz LG. Endotracheal administration of emergency medications. South Med J 1984; 77(3): 340–1

    Article  PubMed  CAS  Google Scholar 

  180. Powers RD, Donowitz LG. Endotracheal administration of emergency medications. South Med J 1984; 77(3): 346 — afeter 178

    Article  Google Scholar 

  181. Alexander R, Pappachan R, Smith GB, Taylor BL. Treatment of acute anaphylaxis: avoid subcutaneous or intramuscular adrenaline [letter; comment]. BMJ 1995; 311(7017): 1434–5

    Article  PubMed  CAS  Google Scholar 

  182. Campbell S. Treatment of acute anaphylaxis: expressing the dose of adrenaline in milligrams is easier [letter; comment]. BMJ 1995; 311(7017): 1435

    Article  PubMed  CAS  Google Scholar 

  183. Raper RF, Fisher MM. Profound reversible myocardial depression after anaphylaxis. Lancet 1988; I(8582): 386–8

    Article  Google Scholar 

  184. Levy JH. New concepts in the treatment of anaphylactoid reactions in anesthesia. Ann Fr Anesth Reanim 1993; 12(2): 223–7

    Article  PubMed  CAS  Google Scholar 

  185. Mitsuhata H, Shimizu R, Yokoyama MM. Role of nitric oxide in anaphylactic shock. J Clin Immunol 1995; 15(6): 277–83

    Article  PubMed  CAS  Google Scholar 

  186. Compton J. Use of glucagon in intractable allergic reactions and as an alternative to epinephrine: an interesting case review. J Emerg Nurs 1997; 23(1): 45–7

    Article  PubMed  CAS  Google Scholar 

  187. Lee ML. Glucagon in anaphylaxis [letter]. J Allergy Clin Immunol 1982; 69(3): 331–2

    Article  PubMed  CAS  Google Scholar 

  188. Zaloga GP, DeLacey W, Holmboe E, et al. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 1986; 105(1): 65–6

    PubMed  CAS  Google Scholar 

  189. Schleimer RP. The mechanisms of antiinflammatory steroid action in allergic diseases. Annu Rev Pharmacol Toxicol 1985; 25: 381–412

    Article  PubMed  CAS  Google Scholar 

  190. Runge JW, Martinez JC, Caravati EM, et al. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 1992; 21(3): 237–42

    Article  PubMed  CAS  Google Scholar 

  191. De Soto H, Turk P. Cimetidine in anaphylactic shock refractory to standard therapy. Anesth Analg 1989; 69: 260–9

    Article  Google Scholar 

  192. Kambam JR, Merrill WH, Smith BE. Histamine-2 receptor blocker in the treatment of protamine related anaphylactoid reactions: two case reports. Can J Anaesth 1989; 36(4): 463–5

    Article  PubMed  CAS  Google Scholar 

  193. Kelly JS, Prielipp RC. Is cimetidine indicated in the treatment of acute anaphylactic shock. Anesth Analg 1990; 71: 104–5

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Professor D. Longrois and Dr W. Canada for their help in reviewing this manuscript.

Author information

Authors and Affiliations

  1. Laboratoire d’Explorations Fonctionnelles Respiratoires et Allergologiques, CHU-Hopital Maison Blanche, Reims, France

    Paul Michel Mertes

  2. Departement d’Anaesthésie-réanimation, CHU-Hopital Central, 54000, Nancy, France

    Marie-Claire Laxenaire

Authors
  1. Paul Michel Mertes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marie-Claire Laxenaire
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie-Claire Laxenaire.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mertes, P.M., Laxenaire, MC. Anaphylaxis During General Anaesthesia. Mol Diag Ther 14, 115–133 (2000). https://doi.org/10.2165/00023210-200014020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200014020-00003

Keywords

Search

Navigation